Chief Executive Officer & Portfolio Manager at Perceptive Advisors
View Live Interactive Profile →Joseph Edelman is the Chief Executive Officer and founder of Perceptive Advisors LLC, a New York City based hedge fund that specialises in biotechnology stocks, which he established in 1999. The firm's page for him says he leads an investment team of MDs and PhDs and that he serves on the Board of Directors at the New York Genome Center and Athira Pharma; SEC records show that the issuer formerly named Athira Pharma, Inc. (CIK 0001620463) is now LeonaBio, Inc. (Nasdaq: LONA), and his Form 4 for the period ended 23 June 2026 reports him as a director of LeonaBio. He earned a Bachelor of Arts in Psychology, graduating magna cum laude from the University of California, San Diego, initially pursued a graduate-level degree in psychopharmacology, and then earned an MBA at the Leonard N. Stern School of Business at New York University. He signs Perceptive Advisors' Form 13F-HR filings as Managing Member.